These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18369476)

  • 21. Polymorphisms in HTLV-1 Tax-responsive elements in HTLV-1-associated myelopathy/tropical spastic paraparesis patients are associated with reduced proviral load but not with disease progression.
    Gomes YCP; Silva MTT; Leite ACCB; Lima MASD; Araújo AQC; Silva Filho IL; Vicente ACP; Espíndola OM
    J Gen Virol; 2021 Sep; 102(9):. PubMed ID: 34494950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
    Primo J; Siqueira I; Nascimento MC; Oliveira MF; Farre L; Carvalho EM; Bittencourt AL
    Braz J Med Biol Res; 2009 Aug; 42(8):761-4. PubMed ID: 19578703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
    Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
    Martins ML; Guimarães JC; Ribas JG; Romanelli LC; de Freitas Carneiro-Proietti AB
    J Neurovirol; 2017 Feb; 23(1):125-133. PubMed ID: 27678093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
    Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
    J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins.
    Nakane S; Shirabe S; Moriuchi R; Mizokami A; Furuya T; Nishiura Y; Okazaki S; Yoshizuka N; Suzuki Y; Nakamura T; Katamine S; Gojobori T; Eguchi K
    J Neurovirol; 2000 Aug; 6(4):275-83. PubMed ID: 10951551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy.
    Kubota R; Fujiyoshi T; Izumo S; Yashiki S; Maruyama I; Osame M; Sonoda S
    J Neuroimmunol; 1993 Feb; 42(2):147-54. PubMed ID: 8429100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Kira J
    Mol Neurobiol; 1994; 8(2-3):139-45. PubMed ID: 7999310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.
    Yakova M; Lézin A; Dantin F; Lagathu G; Olindo S; Jean-Baptiste G; Arfi S; Césaire R
    Retrovirology; 2005 Feb; 2():4. PubMed ID: 15686595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.
    Trindade BC; Sorgi CA; Nicolete LD; Malta TM; Pinto MT; Takayanagui OM; Covas DT; Martins Filho OA; Kashima S; Faccioli LH
    PLoS One; 2012; 7(12):e51873. PubMed ID: 23284797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients.
    Ramirez E; Fernandez J; Cartier L; Villota C; Rios M
    Virus Res; 2003 Feb; 91(2):231-9. PubMed ID: 12573502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection.
    Melamed A; Laydon DJ; Gillet NA; Tanaka Y; Taylor GP; Bangham CR
    PLoS Pathog; 2013 Mar; 9(3):e1003271. PubMed ID: 23555266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.
    Kubota R; Umehara F; Izumo S; Ijichi S; Matsumuro K; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
    J Neuroimmunol; 1994 Aug; 53(1):23-9. PubMed ID: 7914211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil.
    Olavarria VN; Gomes Ado N; Kruschewsky Rde A; Galvão-Castro B; Grassi MF
    Braz J Infect Dis; 2012; 16(4):357-60. PubMed ID: 22846124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H
    Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.